William E. Ford - Jun 30, 2021 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for William E. Ford
Stock symbol
RPRX
Transactions as of
Jun 30, 2021
Transactions value $
$37,489
Form type
4
Date filed
6/30/2021, 05:11 PM
Previous filing
Jun 29, 2021
Next filing
Sep 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $37.5K +871 +15.21% $43.04 6.6K Jun 30, 2021 Direct F1
holding RPRX Class A Ordinary Shares 540K Jun 30, 2021 By Madison Park Capital, LLC F2
holding RPRX Class A Ordinary Shares 1.5M Jun 30, 2021 GA RP Holding, L.P. F3, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects Class A Ordinary Shares issued to the Reporting Person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.
F2 The Reporting Person has a private membership interest in Madison Park Capital, LLC ("MPC"), a U.S. based entity within the General Atlantic private equity group, and is an officer and a member of the Board of Managers of MPC. The ordinary shares reported herein give effect to the distribution of ordinary shares by Groton Restricted Fund LP for no additional consideration to its limited partners. As the distribution of such ordinary shares constituted only a change in the form of the Reporting Person's ownership in such ordinary shares, the Reporting Person was not required to report the distribution pursuant to Section 16. The Reporting Person disclaims ownership of such ordinary shares except to the extent he has a pecuniary interest therein.
F3 The Reporting Person is employed by an entity affiliated with GA RP Holding, L.P. ("GA RP Holding"). The limited partners of GA RP Holding that share beneficial ownership of the ordinary shares held by GA RP Holding are GAP Coinvestments CDA, L.P. ("GAPCO CDA"), GAP Coinvestments III, LLC ("GAPCO III"), GAP Coinvestments IV, L.P. ("GAPCO IV"), GAP Coinvestments V, LLC ("GAPCO V"), General Atlantic Partners (Bermuda) IV, L.P. ("GAP Bermuda IV"), General Atlantic Partners (Bermuda) EU, L.P. ("GAP Bermuda EU") and General Atlantic Partners (Lux), SCSp ("GAP Lux").
F4 GA RP Holding, Ltd. ("GA RP Ltd.") is the general partner of GA RP Holding. General Atlantic LLC ("GA LLC") is the managing member of GAPCO III, GAPCO IV and GAPCO V and the general partner of GAPCO CDA. General Atlantic GenPar (Lux), SCSp ("GA GenPar Lux") is the general partner of GAP Lux, and General Atlantic (Lux) S.a.r.l ("GA Lux Sarl") is the general partner of GA GenPar Lux. General Atlantic GenPar (Bermuda), L.P. ("GA GenPar Bermuda") is the sole shareholder of GA Lux Sarl, and the general partner of GAP Bermuda IV and GAP Bermuda EU. GAP (Bermuda) Limited is the general partner of GA GenPar Bermuda and the sole shareholder of GA RP Ltd.
F5 There are nine members of the management committee of GA LLC (the "GA Management Committee"), and the GA Management Committee is ultimately responsible for the management of GAP (Bermuda) Limited. The Reporting Person is a member of the GA Management Committee and is Chief Executive Officer and a Managing Director of GA LLC.
F6 GA LLC, GA GenPar Bermuda, GAP (Bermuda) Limited, GAPCO III, GAPCO IV, GAPCO V, GAPCO CDA, GAP Bermuda IV, GAP Bermuda EU, GAP Lux, GA RP Ltd, GA GenPar Lux and GA Lux Sarl are a "group" within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934, as amended. Each of the members of the GA Management Committee disclaims ownership of the ordinary shares except to the extent he or she has a pecuniary interest therein.